Ann Geriatr Med Res.
2021 Sep;25(3):170-177. 10.4235/agmr.21.0079.
Cardiovascular Complications of Acetylcholinesterase Inhibitors in Patients with Alzheimer’s Disease: A Narrative Review
- Affiliations
-
- 1Boston University School of Medicine, Boston, MA, USA
- 2Division of Cardiology, Harborview Medical Center, University of Washington School of Medicine, Seattle, WA, USA
- KMID: 2520493
- DOI: http://doi.org/10.4235/agmr.21.0079
Abstract
- While acetylcholinesterase inhibitors are used to treat a wide range of patients with Alzheimer’s disease, acetylcholinesterase inhibitor use has also been associated with a variety of cardiovascular complications, including bradycardia and syncope. Herein, we review the pathophysiology and clinical evidence for cardiovascular complications caused by acetylcholinesterase inhibitors in patients being treated for dementia and discuss options for their management.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Biological Predictors of Alzheimer's Disease Treatment
- Pisa Syndrome in a Patient with Alzheimer's Disease and Concomitant Normal Pressure Hydrocephalus: A Case Report
- Dysarthria after Donepezil
- Alzheimer's Disease: Clinical Trials and Future Perspectives
- PET Radioligands for Imaging of Tau Pathology: Current Status
